IVF Key Statistics, Chart & Performance
The current stock price of IVF is 0.8522 USD. In the past month the price decreased by -38.25%.
IVF Latest News, Press Relases and Analysis
IVF Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.23 | 218.96B | ||
| ISRG | INTUITIVE SURGICAL INC | 68.09 | 207.82B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.1 | 144.75B | ||
| SYK | STRYKER CORP | 27.91 | 140.55B | ||
| BDX | BECTON DICKINSON AND CO | 14.06 | 57.87B | ||
| IDXX | IDEXX LABORATORIES INC | 56.57 | 56.96B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.12 | 49.40B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 19.02 | 39.76B | ||
| RMD | RESMED INC | 25.5 | 36.85B | ||
| DXCM | DEXCOM INC | 36.24 | 26.29B | ||
| PODD | INSULET CORP | 63.25 | 20.33B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.48 | 18.40B |
Related stock screener links
About IVF
Company Profile
INVO Fertility Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Sarasota, Florida and currently employs 28 full-time employees. The company went IPO on 2008-11-11. INVO Fertility Inc., formerly NAYA Biosciences, Inc., is a healthcare services company focused on the fertility marketplace and expanding access to assisted reproductive technology (ART) care for patients in need. Its segments include Fertility Clinic Services, INVOcell Device, and Therapeutics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, in vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution to third party-owned and operated fertility clinics. The INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
Company Info
INVO FERTILITY INC
5582 Broadcast Court
Sarasota FLORIDA US
Employees: 28
Phone: 19788789505
INVO FERTILITY INC / IVF FAQ
What does INVO FERTILITY INC do?
INVO Fertility Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Sarasota, Florida and currently employs 28 full-time employees. The company went IPO on 2008-11-11. INVO Fertility Inc., formerly NAYA Biosciences, Inc., is a healthcare services company focused on the fertility marketplace and expanding access to assisted reproductive technology (ART) care for patients in need. Its segments include Fertility Clinic Services, INVOcell Device, and Therapeutics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, in vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution to third party-owned and operated fertility clinics. The INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
What is the stock price of INVO FERTILITY INC today?
The current stock price of IVF is 0.8522 USD. The price decreased by -5.5% in the last trading session.
Does INVO FERTILITY INC pay dividends?
IVF does not pay a dividend.
How is the ChartMill rating for INVO FERTILITY INC?
IVF has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists IVF stock?
IVF stock is listed on the Nasdaq exchange.
Is INVO FERTILITY INC (IVF) expected to grow?
The Revenue of INVO FERTILITY INC (IVF) is expected to grow by 10.02% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
When does INVO FERTILITY INC (IVF) report earnings?
INVO FERTILITY INC (IVF) will report earnings on 2026-04-28, after the market close.
IVF Technical Analysis
IVF Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to IVF. Both the profitability and financial health of IVF have multiple concerns.
IVF Financial Highlights
Over the last trailing twelve months IVF reported a non-GAAP Earnings per Share(EPS) of -644.61. The EPS decreased by -808.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -155.09% | ||
| ROE | -499.38% | ||
| Debt/Equity | 0.31 |
IVF Forecast & Estimates
5 analysts have analysed IVF and the average price target is 146.88 USD. This implies a price increase of 17135.39% is expected in the next year compared to the current price of 0.8522.
For the next year, analysts expect an EPS growth of 92.84% and a revenue growth 10.02% for IVF